CD4 and inflammatory bowel disease: Abolishment of bacterial translocation by broad-spectrum antibiotic treatment during experimental chronic colitis efficiently blocked iNKT (and conventional CD4+ T cells) activation and cytokine secretion, recapitulating in vivo what observed in vitro and providing a rationale for possible targeted interventions aimed at containing immune cell responses in IBD patients.